BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 26036855)

  • 1. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies.
    Bissay V; Van Malderen SC; Keymolen K; Lissens W; Peeters U; Daneels D; Jansen AC; Pappaert G; Brugada P; De Keyser J; Van Dooren S
    Eur J Hum Genet; 2016 Mar; 24(3):400-7. PubMed ID: 26036855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variability in childhood of skeletal muscle sodium channelopathies.
    Yoshinaga H; Sakoda S; Shibata T; Akiyama T; Oka M; Yuan JH; Takashima H; Takahashi MP; Kitamura T; Murakami N; Kobayashi K
    Pediatr Neurol; 2015 May; 52(5):504-8. PubMed ID: 25724373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.
    Maggi L; Ravaglia S; Farinato A; Brugnoni R; Altamura C; Imbrici P; Camerino DC; Padovani A; Mantegazza R; Bernasconi P; Desaphy JF; Filosto M
    Neurogenetics; 2017 Dec; 18(4):219-225. PubMed ID: 28993909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes.
    Kato H; Kokunai Y; Dalle C; Kubota T; Madokoro Y; Yuasa H; Uchida Y; Ikeda T; Mochizuki H; Nicole S; Fontaine B; Takahashi MP; Mitake S
    J Neurol Sci; 2016 Oct; 369():254-258. PubMed ID: 27653901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.
    Corrochano S; Männikkö R; Joyce PI; McGoldrick P; Wettstein J; Lassi G; Raja Rayan DL; Blanco G; Quinn C; Liavas A; Lionikas A; Amior N; Dick J; Healy EG; Stewart M; Carter S; Hutchinson M; Bentley L; Fratta P; Cortese A; Cox R; Brown SD; Tucci V; Wackerhage H; Amato AA; Greensmith L; Koltzenburg M; Hanna MG; Acevedo-Arozena A
    Brain; 2014 Dec; 137(Pt 12):3171-85. PubMed ID: 25348630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients.
    Vereb N; Montagnese F; Gläser D; Schoser B
    J Neurol; 2021 May; 268(5):1708-1720. PubMed ID: 33263785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of SCN4A gene variation in a Chinese pedigree affected with skeletal muscle sodium channelopathies].
    Lu Y; Yang X; Wang X; Xue P; Zhang J; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Aug; 36(8):809-812. PubMed ID: 31400134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
    Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
    J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations.
    Sun J; Luo S; Suetterlin KJ; Song J; Huang J; Zhu W; Xi J; Zhou L; Lu J; Lu J; Zhao C; Hanna MG; Männikkö R; Matthews E; Qiao K
    Neuromuscul Disord; 2021 Sep; 31(9):829-838. PubMed ID: 33965302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome.
    Rigamonti A; Mantero V; Peverelli L; Pagliarani S; Lucchiari S; Comi G; Gibertini S; Salmaggi A
    Neurol Sci; 2021 Dec; 42(12):5359-5363. PubMed ID: 34378097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic generalized epilepsy in a family with SCN4A-related myotonia.
    Talarico M; Fortunato F; Labalme A; Januel L; Chatron N; Sanlaville D; Sammarra I; Gagliardi M; Procopio R; Valentino P; Annesi G; Lesca G; Gambardella A
    Epilepsia Open; 2024 Jun; 9(3):951-959. PubMed ID: 38544349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-dystrophic myotonia: 2-year clinical and patient reported outcomes.
    Fullam TR; Chandrashekhar S; Farmakidis C; Jawdat O; Pasnoor M; Dimachkie MM; Statland JM;
    Muscle Nerve; 2022 Aug; 66(2):148-158. PubMed ID: 35644941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia.
    Campanale C; Laghetti P; Saltarella I; Altamura C; Canioni E; Iosa E; Maggi L; Brugnoni R; Tacconi P; Desaphy JF
    J Neuromuscul Dis; 2024; 11(3):725-734. PubMed ID: 38427496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.
    Vivekanandam V; Jaibaji R; Sud R; Ellmers R; Skorupinska I; Germaine L; James N; Holmes S; Mannikko R; Jayaseelan D; Hanna MG
    Neuromuscul Disord; 2023 Mar; 33(3):270-273. PubMed ID: 36796140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant.
    Benhammou JN; Phan J; Lee H; Ghassemi K; Parsons W; Grody WW; Pisegna JR
    J Mol Neurosci; 2017 Mar; 61(3):312-314. PubMed ID: 28012096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic spectrum and founder effect of non-dystrophic myotonia: a Japanese case series study.
    Yuan JH; Higuchi Y; Hashiguchi A; Ando M; Yoshimura A; Nakamura T; Sakiyama Y; Takashima H
    J Neurol; 2022 Dec; 269(12):6406-6415. PubMed ID: 35907044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.